Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bevacizumab in Extensive Small Cell Lung Cancer (CPC)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Intergroupe Francophone de Cancerologie Thoracique
ClinicalTrials.gov Identifier:
NCT00930891
First received: July 1, 2009
Last updated: March 9, 2016
Last verified: March 2016